Natriumchlorid Braun (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Braun, is an electrolyte solution presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and correct electrolyte imbalances in patients requiring fluid resuscitation, electrolyte replacement, or blood volume expansion.

GNH USA supplies Natriumchlorid Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, providing regulated, quality‑assured products to healthcare facilities across multiple regions.

Natriumchlorid Braun is used in clinical situations that require rapid restoration of fluid and electrolyte balance.

Fluid resuscitation: restores intravascular volume in patients with hypovolemia or hemorrhagic shock. Electrolyte replacement: supplies sodium and chloride ions to correct hyponatremia or chloride deficits. Blood volume expansion: increases circulating blood volume during surgery or severe dehydration.

Intravenous administration of sodium chloride may be associated with several adverse reactions.

Common Side Effects: - Injection site pain or irritation: mild discomfort or redness at the catheter entry point, usually resolving without intervention. - Transient mild hypernatremia: temporary rise in serum sodium that normalizes after fluid redistribution. - Peripheral edema: slight swelling of extremities due to increased extracellular fluid, often self‑limiting.

Serious or Rare Side Effects: - Severe hypernatremia with neurologic signs: marked elevation of serum sodium causing confusion, seizures, or coma. - Pulmonary edema from fluid overload: accumulation of fluid in the lungs leading to dyspnea and reduced oxygenation. - Allergic reaction including anaphylaxis: rare hypersensitivity presenting with rash, bronchospasm, or circulatory collapse.

Before administering Natriumchlorid Braun, consider the following precautions.

Renal function: evaluate kidney performance before large‑volume infusion to avoid fluid accumulation. Cardiac status: monitor for signs of overload in patients with heart failure or coronary disease. Electrolyte balance: avoid use in patients with existing hypernatremia or hyperchloremia. Pediatric dosing: calculate volume carefully based on weight and monitor vital signs. Pregnancy: administer only when clearly indicated, after risk‑benefit assessment. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Natriumchlorid Braun may interact with other therapies; awareness of these interactions helps ensure safe use.

Major Interactions (Avoid): - Concomitant hypertonic saline solutions: risk of severe hypernatremia and osmotic injury. - Use with diuretics that cause sodium loss: may exacerbate electrolyte depletion.

Moderate Interactions (Monitor Closely): - Co‑administration with potassium‑rich IV fluids: monitor serum potassium levels. - Combination with ACE inhibitors or ARBs: increased risk of fluid retention and hypertension. - Concurrent corticosteroid therapy: potential for enhanced fluid retention and edema.